These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23881602)

  • 1. Rosiglitazone promotes the differentiation of Langerhans cells and inhibits that of other dendritic cell types from CD133 positive hematopoietic precursors.
    Bonetti MI; Bacci S; Santosuosso M; Mazzanti B; Aldinucci A; Ballerini C; Guasti D; Calosi L; Bosi A; Romagnoli P
    Histol Histopathol; 2014 Mar; 29(3):323-32. PubMed ID: 23881602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells with lymphocyte-stimulating activity differentiate from human CD133 positive precursors.
    Bonetti MI; Pieri L; Domenici L; Urbani S; Romano G; Aldinucci A; Ballerini C; Monici M; Saccardi R; Basile V; Bosi A; Romagnoli P
    Blood; 2011 Apr; 117(15):3983-95. PubMed ID: 21304102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD34+ CD11b- cord blood stem cells generate in vitro a CD34- CD11b+ subset that is enriched in langerin+ Langerhans dendritic cell precursors.
    Soulas C; Arrighi JF; Saeland S; Chapuis B; Kindler V
    Exp Hematol; 2006 Nov; 34(11):1471-9. PubMed ID: 17046566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage.
    Ruzicka K; Grskovic B; Pavlovic V; Qujeq D; Karimi A; Mueller MM
    Clin Chim Acta; 2004 May; 343(1-2):85-92. PubMed ID: 15115679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B; Camus S; Yagello M; Gluckman JC
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood CD34+ cells differentiate into dermal dendritic cells in co-culture with cutaneous fibroblasts or stromal cells.
    Mollah ZU; Aiba S; Manome H; Yoshino Y; Tagami H
    J Invest Dermatol; 2002 Mar; 118(3):450-60. PubMed ID: 11874484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response.
    Sioud M; Fløisand Y
    Eur J Immunol; 2007 Oct; 37(10):2834-46. PubMed ID: 17853407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human blood BDCA-1 dendritic cells differentiate into Langerhans-like cells with thymic stromal lymphopoietin and TGF-β.
    Martínez-Cingolani C; Grandclaudon M; Jeanmougin M; Jouve M; Zollinger R; Soumelis V
    Blood; 2014 Oct; 124(15):2411-20. PubMed ID: 25114264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for transforming growth factor-beta1 in maintaining the differentiated state of Langerhans cells in human epidermis.
    Pieri L; Domenici L; Romagnoli P
    Ital J Anat Embryol; 2006; 111(3):133-49. PubMed ID: 17312920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors.
    de Wynter EA; Buck D; Hart C; Heywood R; Coutinho LH; Clayton A; Rafferty JA; Burt D; Guenechea G; Bueren JA; Gagen D; Fairbairn LJ; Lord BI; Testa NG
    Stem Cells; 1998; 16(6):387-96. PubMed ID: 9831864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new methodological sequence to expand and transdifferentiate human umbilical cord blood derived CD133+ cells into a cardiomyocyte-like phenotype.
    Cui YX; Kafienah W; Suleiman MS; Ascione R
    Stem Cell Rev Rep; 2013 Jun; 9(3):350-9. PubMed ID: 21948151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro identification of a cord blood CD133+CD34-Lin+ cell subset that gives rise to myeloid dendritic precursors.
    Goussetis E; Theodosaki M; Paterakis G; Tsecoura C; Graphakos S
    Stem Cells; 2006 Apr; 24(4):1137-40. PubMed ID: 16339995
    [No Abstract]   [Full Text] [Related]  

  • 17. A skin homing molecule defines the langerhans cell progenitor in human peripheral blood.
    Strunk D; Egger C; Leitner G; Hanau D; Stingl G
    J Exp Med; 1997 Mar; 185(6):1131-6. PubMed ID: 9091586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?
    Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR
    Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner.
    Jaksits S; Kriehuber E; Charbonnier AS; Rappersberger K; Stingl G; Maurer D
    J Immunol; 1999 Nov; 163(9):4869-77. PubMed ID: 10528188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.